GRRMY (Gerresheimer AG) FCF Margin % : -2.17% (As of Aug. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Gerresheimer AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gerresheimer AG's Free Cash Flow for the three months ended in Aug. 2024 was $-12 Mil. Gerresheimer AG's Revenue for the three months ended in Aug. 2024 was $550 Mil. Therefore, Gerresheimer AG's FCF Margin % for the quarter that ended in Aug. 2024 was -2.17%.

As of today, Gerresheimer AG's current FCF Yield % is -4.72%.

The historical rank and industry rank for Gerresheimer AG's FCF Margin % or its related term are showing as below:

GRRMY' s FCF Margin % Range Over the Past 10 Years
Min: -5.97 Med: 3 Max: 7.61
Current: -5.97

During the past 13 years, the highest FCF Margin % of Gerresheimer AG was 7.61%. The lowest was -5.97%. And the median was 3.00%.

GRRMY's FCF Margin % is ranked worse than
51.76% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -4.42 vs GRRMY: -5.97

Gerresheimer AG FCF Margin % Historical Data

The historical data trend for Gerresheimer AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG FCF Margin % Chart

Gerresheimer AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

FCF Margin %

Get a 7-Day Free Trial

2.08

3.46

0.56

-1.08

-1.69

Gerresheimer AG Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
FCF Margin %	Get a 7-Day Free Trial															15.43	9.66	-18.95	-14.78	-2.17

Competitive Comparison of Gerresheimer AG's FCF Margin %

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gerresheimer AG's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's FCF Margin % falls into.

Gerresheimer AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gerresheimer AG's FCF Margin for the fiscal year that ended in Nov. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Nov. 2023 )	/	Revenue (A: Nov. 2023 )
	=	-36.471	/	2154.206
	=	-1.69 %

Gerresheimer AG's FCF Margin for the quarter that ended in Aug. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Aug. 2024 )	/	Revenue (Q: Aug. 2024 )
	=	-11.93	/	549.63
	=	-2.17 %

Gerresheimer AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (OTCPK:GRRMY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

GXId:UK 0NTI:UK GXI:Germany GXI:Germany GXI:Germany GXI:Germany GXI:Austria

Address

Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468

Website

https://www.gerresheimer.com

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.